日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The impact of testosterone on paraventricular nucleus gene expression in male and female spontaneously hypertensive rats

睾酮对雄性和雌性自发性高血压大鼠室旁核基因表达的影响

Paterson, Alex; Loh, Su-Yi; Gholami, Shadi Kadijeh; Rogers, Mark F; Murugan, Dharmani Devi; Sau-Kuen, Lam; Mustafa, Mohammad Rais; Ott, Benjamin P; Balaratnam, Prusha; Mecawi, Andre S; Murphy, David; Hindmarch, Charles C T

TURALIO® Risk Evaluation and Mitigation Strategy (tREMS) program: 5-year retrospective hepatic safety assessment

TURALIO® 风险评估和缓解策略 (tREMS) 项目:5 年回顾性肝脏安全性评估

Waheed Rajper, Abdul; Dharmani, Charles; Chilakapati, Lalitha; Fofah, Oluwatosin; Wooddell, Margaret J

Des-Aspartate Angiotensin-1: A Dual-Targeted Therapeutic for Perivascular Inflammation and Vascular Dysfunction in Obesity

去天冬氨酸血管紧张素-1:一种治疗肥胖症中血管周围炎症和血管功能障碍的双靶点疗法

Mandal, Ashok Kumar; Kadir, Sharifah Zamiah Syed Abdul; Ugusman, Azizah; Murugan, Dharmani Devi

Identifying ventricular arrhythmia and sudden cardiac arrest in clinical notes of an electronic health record database

在电子健康记录数据库的临床记录中识别室性心律失常和心脏骤停

Dhopeshwarkar, Neil; Dharmani, Charles; Fofah, Oluwatosin; Tu, Nora; Khan, Nasser; Kou, Tzuyung Douglas; Chan, K Arnold

Editorial: Epigenetic and genetic mechanisms underlying cardiovascular diseases and neurodevelopmental disorders

社论:心血管疾病和神经发育障碍的表观遗传和遗传机制

Zhang, Peng; Gou, Lingshan; Murugan, Dharmani Devi; Zhang, Hongsong

Real-world drug utilization and treatment patterns in patients with tenosynovial giant cell tumors in the USA

美国腱鞘巨细胞瘤患者的真实世界药物使用和治疗模式

Dharmani, Charles; Fofah, Oluwatosin; Wang, Eric; Salas, Maribel; Wooddell, Margaret; Tu, Nora; Tse, Jenny; Near, Aimee; Tinoco, Gabriel

TURALIO(®) Risk Evaluation and Mitigation Strategy Program (tREMS): 3-year retrospective hepatic safety assessment

TURALIO® 风险评估和缓解策略计划 (tREMS):3 年回顾性肝脏安全性评估

Dharmani, Charles; Fofah, Oluwatosin; Fallon, Maura; Rajper, Abdul Waheed; Wooddell, Margaret; Salas, Maribel

Potential biomarkers in breast cancer drug development: application of the biomarker qualification evidentiary framework

乳腺癌药物研发中的潜在生物标志物:生物标志物鉴定证据框架的应用

Wang, Eric; Henderson, Mackenzie; Yalamanchili, Priyanka; Cueto, Jenilee; Islam, Zahidul; Dharmani, Charles; Salas, Maribel

Exploring the perspectives of pharmaceutical experts and healthcare practitioners on senolytic drugs for vascular aging-related disorder: a qualitative study

探讨药学专家和医疗保健从业人员对用于治疗血管老化相关疾病的衰老细胞清除药物的看法:一项定性研究

Wong, Li Ping; Alias, Haridah; Tan, Kit Mun; Wong, Pooi Fong; Murugan, Dharmani Devi; Hu, Zhijian; Lin, Yulan

Natural Bioactive Compounds Targeting NADPH Oxidase Pathway in Cardiovascular Diseases

靶向NADPH氧化酶通路治疗心血管疾病的天然生物活性化合物

Sofiullah, Siti Sarah M; Murugan, Dharmani Devi; Muid, Suhaila Abd; Seng, Wu Yuan; Kadir, Sharifah Zamiah Syed Abdul; Abas, Razif; Ridzuan, Nurul Raudzah Adib; Zamakshshari, Nor Hisam; Woon, Choy Ker